Skip to content
GLP-1 Scorecard
Menu

Site position #27

bmiMD

By GLP-1 ScorecardUpdated
Offer review: November 2026. Factor scores were not reassessed in this update.

bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.

Our take

bmiMD is worth comparing for a cash-pay compounded prescription, but we would start with the shorter commitment. Its lowest advertised rates require substantial prepayment, while cancellation must be completed before the renewal authorization. Get the dispensing pharmacy and written exit terms before choosing a long plan.

Is it for you?Best fit and reasons to look elsewhere
Best for
Adults considering clinician-prescribed compounded treatment who can manage an early renewal deadline and want to compare one-month pricing with prepaid discounts.
Look elsewhere if
Anyone seeking an easily refundable annual trial, an immediately named dispensing pharmacy or a subscription they can stop merely by sending an email.
Semaglutide
$129/mo on the one-month plan ($99/mo equivalent with $1,188 prepaid for 12 months)
Tirzepatide
$179/mo on the one-month plan ($139/mo equivalent with $1,668 prepaid for 12 months)
Coverage
All 50 states
Brand-name
Not confirmed
In this review
Visit bmiMDWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Weigh bmiMD against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives before comparing prices. The trial evidence behind the drugs themselves is in our research library, kept separate from these grades. Every listing is graded on the same six factors as this one. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe before you order. Compounded preparations are not FDA-approved, so the pharmacy and prescriber matter.

The current product pages list semaglutide at $129 for one month, $357 for three, $654 for six or $1,188 for twelve. Tirzepatide is $179, $477, $894 or $1,668 respectively. Longer plans are prepaid; the lowest monthly equivalents are $99 and $139 on twelve-month commitments. These figures are lower than the ones we recorded in October, and both pages label them as limited-time.

The annual discount is a large purchase

bmiMD gives a shopper concrete plan totals rather than only a teaser price. Semaglutide costs $129 for one month, $357 for three months, $654 for six or $1,188 for twelve. Tirzepatide costs $179, $477, $894 or $1,668 over those same terms. Both pages advertise the same price across doses, a provider visit and shipping. The $99 and $139 monthly figures are twelve-month equivalents. Each plan also prints a higher monthly figure beside its price under a limited-time label, so confirm the amount on the order page before paying.

The difference matters if you are new to treatment or transferring care. A lower allocated monthly cost comes with a much larger initial payment. Compare the actual upfront amount and refund exposure before deciding that the annual option is better value. We would first establish whether the medication, clinical follow-up and dispensing arrangement fit your needs; the largest discount cannot answer those questions.

Monthly billing can arrive before the calendar turns

The billing help page says monthly plans renew every 28 days. The October 15 terms allow a 28-to-30-day interval. Multi-month plans renew for another prepaid term, with medication shipped in installments. Ask which exact interval and renewal amount apply to your offer.

A four-week cycle is different from paying on the same date every month. For illustration, thirteen 28-day periods cover 364 days; this is scheduling arithmetic, not a prediction of your account. Ask for the next several charge dates and how they match your refill schedule. A twelve-month title also should not be assumed to guarantee twelve identical calendar-month shipments without a written supply schedule.

The refill guide says injection programs ship one vial at a time, including prepaid plans. Paying for a year therefore does not mean receiving a year of medication at once. Confirm the number of installments and how a clinician reviews dose changes between shipments.

If the price or terms here do not fit, our Wellorithm review and our MEDGm review set out the prices, renewal terms and what we could not verify for each. Both sellers pay us a commission when a reader signs up, which never changes a grade.

Cancel before authorization, and verify the result

The refund policy requires cancellation by 11:59 p.m. Eastern at least seven days before renewal. The terms express the cutoff as 48 hours before a renewal authorization placed approximately five days before the renewal date. Those descriptions broadly point to the same early deadline, but the actual portal date matters.

There is a more consequential difference about method: the refund page permits account controls or email, while the terms say email alone does not cancel. The terms require a canceled status in the portal or Help Center confirmation when you cannot log in. We would use the portal, save confirmation and resolve access problems before the cutoff.

Do not wait for a shipping email to decide. Ask how pausing differs from canceling, which pending order is affected and when a longer plan would renew for another full term. A pause should have an identifiable effect on both billing and fulfillment.

Eligibility protection is narrower than a free trial

The initial order uses an authorization hold, with collection after clinical approval and release if treatment is declined. The terms impose a $100 cancellation fee after intake submission but before review begins, and say the initial order cannot be canceled once review starts. The separate help article describes a $100 cancellation window after approval. Obtain an explanation of that timing before submitting an intake.

The important distinction is medical rejection versus voluntarily changing your mind. An eligibility promise does not make an approved prescription a satisfaction trial. If you have questions about the intended medication, other conditions or the service arrangement, raise them before approval rather than assuming you can investigate afterward and recover the payment.

The refund policy says a released hold usually disappears within seven to ten business days, depending on the bank. Leave room for that temporary hold when assessing the amount you can authorize. We did not place an order or test that timing.

Prepaid refunds depend on why treatment ends

After the initial order reaches the pharmacy, prepaid plan payments generally are not refundable for voluntary cancellation, pauses or disappointing results. The policy offers remaining shipments or purchase credit. Documented medical cancellation by the provider has a separate credit-or-refund provision, deducting completed shipments. If a remaining installment cannot be supplied because of availability or regulatory changes, the policy offers an approved alternative or credit.

These are different exit situations. Ask for a worked refund example using your chosen plan, including how completed shipments are valued. Also ask whether an unfulfillable remaining installment can receive a cash refund in your circumstances. Someone unable to use another program should not count account credit as equivalent to money returned. We would want that answer before making a large prepayment.

Messaging access needs a realistic clinical expectation

The product pages advertise provider messaging and broad access. The dedicated portal guide gives a more practical expectation: a typical clinician reply within 24–48 hours, for non-urgent communication. It identifies dose changes, side effects and maintenance planning as clinical topics. That is an advertised response range, not a service test or guaranteed appointment.

Ask who will review your history, what follow-up is scheduled and whether any laboratory testing costs extra. The terms allow the clinician to request labs or recommend in-person care. A purchase does not guarantee your preferred prescription or dose.

The program may suit someone comfortable managing care through messages. Someone who needs regular live visits should obtain that schedule explicitly. The presence of a portal and ongoing messaging does not establish the same experience as a dedicated local clinician.

The pharmacy still needs to be identified for your order

The terms identify Medccm, Inc., doing business as bmiMD, as the technology platform. They say the treating provider and dispensing pharmacy appear in patient documents; the public material reviewed did not establish an assigned team for this investigation. We did not independently verify a clinician or pharmacy license.

Ask for the pharmacy legal name, address and authorization to dispense to your state, then check the relevant board record. Broad licensed-pharmacy language and quality-testing claims do not identify the actual compounder or prove an individual batch. The terms acknowledge that compounded drugs are not FDA-approved. Discuss the particular formulation and clinical rationale with the prescriber.

Both injection pages advertise all-state availability, but your program and location still need confirmation. We reviewed public pages on October 25, 2026, without enrollment, medication use or support contact. Our recommendation remains conditional on an identified care team, a complete quote and cancellation instructions you can actually follow.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value88/100
Dose & formulation82/100
Clinical oversight70/100
Labs & monitoring72/100
Fulfillment84/100
Contract terms74/100

Strengths

  • Advertises the same price across prescribed doses for each selected injection plan
  • Publishes compounded semaglutide and tirzepatide injection plans
  • Every rung of both ladders is published with the total charge beside each per-month figure
  • All 50 states

What to consider

  • The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
  • The annual $99 and $139 monthly equivalents require $1,188 or $1,668 paid upfront for 12 months
  • A higher $229 and $349 monthly figure is printed beside every plan price under a standing LIMITED TIME label, with no published basis
  • Neither the compounding pharmacy nor the prescribing group is named on the product pages

Bottom line — Grade C+

Factor scores not reassessed.

Site position #27 of 515. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest bmiMD — the realistic shortlist.

The 19 rankings nearest this one

View full scorecard rankings →

Prices and terms can change; confirm them with bmiMD. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard